levodopa and jaw
levodopa has been researched along with jaw in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jeste, DV; Karson, CN; LeWitt, PA; Wyatt, RJ | 1 |
| Hammerstad, JP; Robertson, LT | 1 |
| Betz, AJ; Bibbiani, F; Chase, TN; Davis, RE; Kielaite, A; Salamone, JD; Vanover, KE; Weber, SM; Weiner, DM | 1 |
| Ballero, M; Kasture, S; Longoni, R; Morelli, M; Pinna, A; Pontis, S; Schintu, N; Simola, N; Spina, L | 1 |
| Cristalli, G; Morelli, M; Pinna, A; Pontis, S; Schintu, N; Simola, N; Tronci, E; Volpini, R | 1 |
| Burchiel, KJ; Carlson-Kuhta, P; Hogarth, P; Horak, FB; Robertson, LT; St George, RJ | 1 |
| LeDoux, MS; Pfeiffer, RF | 1 |
| Amernik, K; Gołąb-Janowska, M; Honczarenko, K; Nowacki, P; Pawlukowska, W; Rotter, I; Safranow, K | 1 |
Trials
2 trial(s) available for levodopa and jaw
| Article | Year |
|---|---|
Jaw movement dysfunction related to Parkinson's disease and partially modified by levodopa.
Topics: Antiparkinson Agents; Electromagnetic Fields; Electromyography; Female; Humans; Jaw; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease | 1996 |
Site of deep brain stimulation and jaw velocity in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Biomechanical Phenomena; Combined Modality Therapy; Deep Brain Stimulation; Deglutition Disorders; Double-Blind Method; Female; Globus Pallidus; Humans; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Speech Disorders; Subthalamic Nucleus; Treatment Outcome | 2011 |
Other Studies
6 other study(ies) available for levodopa and jaw
| Article | Year |
|---|---|
A comparison of two iatrogenic dyskinesias.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Extremities; Facial Muscles; Female; Humans; Iatrogenic Disease; Jaw; Levodopa; Male; Middle Aged; Parkinson Disease; Tongue | 1983 |
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model.
Topics: Animals; Data Interpretation, Statistical; Dopamine Agents; Dyskinesia, Drug-Induced; Jaw; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Tremor; Urea | 2008 |
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Antiparkinson Agents; CD11b Antigen; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Jaw; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Movement; Mucuna; Neuroprotective Agents; Oxidopamine; Parasympathomimetics; Parkinson Disease; Phytotherapy; Rats; Rats, Sprague-Dawley; Seeds; Sympatholytics; Tacrine; Time Factors; Vibrissae | 2009 |
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Brain Chemistry; CD11b Antigen; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Gene Expression Regulation; Jaw; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Movement; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotarod Performance Test; Time Factors; Triazoles; Vibrissae | 2010 |
Levodopa-induced lateral jaw deviation dystonia.
Topics: Aged; Dystonia; Female; Humans; Jaw; Levodopa | 2015 |
Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Articulation Disorders; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Jaw; Levodopa; Lip; Male; Middle Aged; Parkinson Disease; Phonation; Phonetics; Range of Motion, Articular; Reflex, Abnormal; Respiration; Severity of Illness Index | 2015 |